Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Other Non-current Liabilities
Long-term obligations not reported separately, such as lease or pension liabilities.
Other Non-current Liabilities history
Currency unavailable · from the balance sheet
No Other Non-current Liabilities data reported for this period type.
Other Non-current Liabilities vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $336.26M USD | +80.7% | +13.9% | 16.0% | |
| Mar 2026 | $206.34M USD | -29.9% | +8.7% | 27.7% | |
| Mar 2026 | $4.33M USD | -10.0% | +194.3% | 2.7% | |
VCREVicore Pharma Holding AB | Jun 2026 | SEK 330.36K SEK | — | — | 0.3% |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -10.0% | +13.9% | 9.3% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.